Admissions

Education

Samuel Waxman is a partner in the Mergers and Acquisitions and Technology Transactions practices at Paul Hastings. He is based in the firm’s New York office.

Mr. Waxman’s practice focuses on mergers and acquisitions, securities offerings, joint ventures, and intellectual property licenses, with a particular emphasis on companies for whom technology or intellectual property is a key asset. He also represents venture investment funds and emerging technology companies, and is experienced in structuring and negotiating angel and venture financing. His clients range in size from Fortune 100 firms to emerging-stage companies in such diverse industries as pharmaceuticals, medical devices, data security, mobile devices, networking equipment and biotechnology. Mr. Waxman lectures on intellectual property licensing issues at Cornell Tech, the technology-focused campus of Cornell University located in New York City.

Experience

Venture Capital & Minority Investments

Deerfield Management, in connection with various debt and minority equity investments.

Tuatara Capital, in connection with various debt and minority equity investments.

Ascent Biomedical Ventures, in connection with various debt and minority equity investments.

Orchestra Medical Ventures, in connection with various debt and minority equity investments.

BlackIvy Group, in connection with various debt and minority equity investments.

Deerfield Management, in connection with its early-stage therapeutic research partnerships with The Broad Institute of MIT and Harvard and with Johns Hopkins University.

Deerfield Management, Takeda Pharmaceutical Company and Bay City Capital, in connection with the formation of Bridge Medicines, a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine.

Mergers & Acquisitions and Joint Ventures

Merck & Co. in connection with various M&A transactions.

Elanco U.S., Inc., a subsidiary of Eli Lilly and Company, in its acquisition of Boehringer Ingelheim Vetmedica’s U.S. feline, canine and rabies vaccines portfolio.

Formation counsel to Technicolor and Sony Corporation's joint patent licensing program for digital television (DTV) and computer display monitor (CDM).

Atos SE in connection with its acquisition of Anthelios Healthcare Solutions.

HIG Capital in connection with its acquisition of Salary.com.

Lead counsel to Intellectual Ventures and a consortium of 12 of the largest technology companies in the world in connection with the acquisition and licensing of Eastman Kodak Company’s digital imaging patent portfolio.

Thomson Reuters in connection with various M&A transactions.

Vector Capital in connection with various M&A and technology licensing transactions.

The Dow Chemical Company in connection with various M&A and technology licensing transactions.

Boston Scientific Corporation in connection with various M&A and technology licensing transactions.

Accolades and Recognitions

Recognized as a leading technology and intellectual property lawyer in the Financial Times Innovative Lawyers Report and by Legal 500

Intellectual Asset Management’s Patent 1000: The World’s Leading Patent Practitioners stated, “The ‘street-smart’ lawyer has made the most of an outstanding transactional platform at the firm and proved his mettle on some of the biggest acquisitions/divestitures around.”

Named to the top “40 Under 40 M&A Professionals” in M&A Advisor (2012)

Upcoming Events

Rankings & Awards

Paul Hastings IP Practice Honored in IAM Patent 1000

Intellectual Asset Management highlighted Paul Hastings' IP practice in IAM Patent 1000: The World's Leading Patent Professionals. The guide ranked the firm's practices Nationwide as well as in New York and Washington, DC.

Paul Hastings attorneys were also recognized in IAM's Nationwide tables: Yar Chaikovsky and Blair Jacobs were recommended for International Trade Commission litigation; Jacobs was recommended for his experience in Federal Circuit appellate litigation; and Naveen Modi and Joseph Palys were both recognized for their strength in post-grant proceedings.

Preston Ratliff was also noted in the IAM Strategy 300, which recognizes individuals for their work in protecting intellectual property as a key business asset.

June 06, 2017

Chambers USA 2017: America’s Leading Lawyers for BusinessChambers USA 2017: America’s Leading Lawyers for Business named 46 of the firm’s practice areas and 112 individuals to its ranking of leading lawyers and law firms in the United States.
June 05, 2017